Abstract:Abstract Whole genome sequencing (WGS) is increasingly used in both research and clinical settings. The Variant Call Format (VCF) specification is a widely adopted file format for genetic variation data exchange partially due to its smaller file size compared to raw WGS BAMs. Each variant in a typical VCF file contains its chromosome position, reference/alternative alleles and corresponding allele counts. This makes it possible to identify copy number alterations (CNAs). To this end, we developed VCF2CNA (http://vcf2cna.stjude.org), a web interface tool for CNA analysis from VCF files. A user of VCF2CNA, uploads a VCF file via the provided web interface. The entire analysis runs remotely with an average run time of 23 minutes. Results are emailed to the user as either a downloadable link or file attachments. VCF2CNA also accepts input in the Mutation Annotation Format (MAF) and the variant file format produced by the Bambino program. We analyzed 22 TCGA glioblastoma tumor/normal pairs by Illumina technology to evaluate VCF2CNA’s performance. It achieved high consistency (average F1-score: 0.952 ± 0.082) with CONSERTING, a tool that incorporated read-depth and SV data from raw BAMs for CNA detection. A segment-by-segment comparison between results from CONSERTING and VCF2CNA indicated that the latter was less sensitive to focal CNAs. This is expected because there is less information in the VCF input than in raw BAMs. Further analysis using samples with a “fractured genome” pattern revealed that VCF2CNA was more robust to library artifacts and produced relatively clean CNA profiles (on average 76.2-fold reduction compared to the number of segments reported by CONSERTING). Finally, we analyzed 137 pediatric neuroblastoma samples from the TARGET project, sequenced by Complete Genomics, Inc. (CGI) technology. MYCN amplification has been clinically validated in 33 samples. VCF2CNA identified high amplitude MYCN gains in 32 samples and the remaining sample carried a low-level broad gain covering MYCN. For comparison, CGI’s HMM-based method reported MYCN gains in only 15 out of the 33 samples. VCF2CNA further identified two additional MYCN amplifications among the remaining samples. Collectively, our analysis suggests that VCF2CNA is a platform-independent, efficient, robust and accurate tool for general WGS-based CNA analysis. It further complements CONSERTING, which produces more accurate result in focal CNAs at the cost of significantly higher computational burden. Citation Format: Daniel K. Putnam, Xiaotu Ma, Stephen V. Rice, Yu Liu, Jinghui Zhang, Xiang Chen. VCF2CNA: a tool for efficiently detecting copy number alteration using VCF genotype data [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 2587. doi:10.1158/1538-7445.AM2017-2587

TAGCNA: A Method to Identify Significant Consensus Events of Copy Number Alterations in Cancer

Copy Number Aberrations from Affymetrix SNP 6.0 Genotyping Data-How Accurate Are Commonly Used Prediction Approaches?

Genome-wide Identification of Significant Aberrations in Cancer Genome

Accuracy Of Cnv Detection From Gwas Data

Comparative Analysis of Methods for Identifying Recurrent Copy Number Alterations in Cancer.

Abstract 2487: CONSERTING: an Accurate Method for Detecting Focal and Gross Somatic Copy Number Alterations in Cancer Genome by Next Generation Sequencing

SCONCE: a method for profiling copy number alterations in cancer evolution using single-cell whole genome sequencing

SCCNAInfer: a robust and accurate tool to infer the absolute copy number on scDNA-seq data

Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors

The Repertoire of Copy Number Alteration Signatures in Human Cancer

A CNV Computational Model for Clonal Origin Analysis of Synchronous Multifocal Hepatobiliary and Pancreatic Tumors.

SAAS-CNV: A Joint Segmentation Approach on Aggregated and Allele Specific Signals for the Identification of Somatic Copy Number Alterations with Next-Generation Sequencing Data.

Genome-wide Somatic Copy Number Alteration Analysis and Database Construction for Cervical Cancer.

Abstract 2587: VCF2CNA: a Tool for Efficiently Detecting Copy Number Alteration Using VCF Genotype Data

Computational validation of clonal and subclonal copy number alterations from bulk tumor sequencing using CNAqc

Copy Number Analysis Of Whole-Genome Data Using Bic-Seq2 And Its Application To Detection Of Cancer Susceptibility Variants

CaSNP: a Database for Interrogating Copy Number Alterations of Cancer Genome from SNP Array Data

Identification of Driver Copy Number Alterations in Diverse Cancer Types and Application in Drug Repositioning

The Landscape of Somatic Copy Number Alterations in Head and Neck Squamous Cell Carcinoma

Robust analysis of allele-specific copy number alterations from scRNA-seq data with XClone

Genome-Wide Identification of Somatic Aberrations from Paired Normal-Tumor Samples